Abstract:Abstract Colorectal cancer (CRC) is the third leading cause of cancer-related deaths in men and women in the United States. We have shown that tumors from female CRC patients have increased asparagine (Asn) which is positively associated with poorer overall survival for female patients only (n=196, stage I-III). Furthermore, analysis of asparagine synthetase (ASNS) expression shows that ASNS is similarly associated with poorer survival for females with CRC only. Currently it is not understood why there are sex-specific differences in tumor metabolism of Asn, or the roles of ASNS in CRC progression. Therefore, we hypothesize that limiting ASNS-driven Asn production is a viable target to suppress CRC development in a sex-specific manner. Therefore, we used a combination of in vitro and in vivo models with human CRC ASNS knock out (KO) cells to generate additional hypotheses that may reveal mechanisms that underlie this finding. Using a 3D spheroid model, we cultured HCT116 ASNS KO and isogenic HCT116 ASNS WT cell lines and modulated Asn supply. During 7 days of growth, depletion of Asn slowed the growth of ASNS KO cells compared to WT, whereas Asn supplementation (400 μM) recovered growth in both cell lines; however, spheroid growth was less in the KO cells. Subcutaneous xenograft of these cell lines in male and female mice (n=10/genotype/sex) showed that loss of ASNS reduced tumor burden in both male and female mice, and improved survival in female mice alone. Pathological assessment of tumors indicated poorly differentiated carcinoma and presence of viable tumor mass in both groups. However, the mitotic activity index, and cellular proliferation (measured by Ki67 staining) was significantly reduced in female ASNS KO mice compared to ASNS WT, showing that the tumor cells with ASNS KO are growing slower than those of ASNS WT counterparts. A multi-omics approach was then used to investigate metabolic pathways and signaling networks altered between the tumor genotypes. Tumor tissue metabolomics revealed significant decreases in nucleotides, amino acids, fatty acids within the ASNS KO compared to WT tumors. Using RNA-Seq, gene set enrichment and Ingenuity Pathway Analysis (IPA), data were integrated revealing disruption to Wnt/B-catenin signaling and immune responses associated with ASNS KO in female mice. Serum metabolomics also revealed a higher ratio of circulating glutamine to glutamate in the female mice with ASNS KO xenografts compared to WT, and a decreased expression of the tumor aspartate-glutamate transporter SLC1A3, therefore tumors with ASNS KO could have decreased ability to transport metabolites needed for Asn generation. In summary we identified that lack of ASNS suppresses tumor progression in a pre-clinical CRC model, and significantly improves survival in female mice only. Validation and further mechanistic experiments will reveal the robustness of this finding. Citation Format: Caroline Johnson, Oladimeji Aladelokun, Sajid Khan. Asparagine metabolism is linked to sex differences in colorectal cancer growth [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2023; Part 1 (Regular and Invited Abstracts); 2023 Apr 14-19; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2023;83(7_Suppl):Abstract nr 6030.

Loss of Asparagine Synthetase Suppresses the Growth of Human Lung Cancer Cells by Arresting Cell Cycle at G0/G1 Phase

Knockdown of Asparagine Synthetase (asns) Suppresses Cell Proliferation and Inhibits Tumor Growth in Gastric Cancer Cells

Asparagine synthetase regulate -catenin dependent lung cancer metastasis.

Asparagine synthetase regulates lung-cancer metastasis by stabilizing the β-catenin complex and modulating mitochondrial response

Suppression of Asparagine Synthetase Enhances the Antitumor Potency of ART and Artemalogue SOMCL-14-221 in Non-Small Cell Lung Cancer.

Asparagine synthetase is an independent predictor of surgical survival and a potential therapeutic target in hepatocellular carcinoma

Growth characteristics of HCT116 xenografts lacking asparagine synthetase vary according to sex

Enhanced Expression of Asparagine Synthetase under Glucose-Deprived Conditions Promotes Esophageal Squamous Cell Carcinoma Development

Overexpression of TSPAN8 Promotes Tumor Cell Viability and Proliferation in Nonsmall Cell Lung Cancer.

Differential effect of asparagine and glutamine removal on three adenocarcinoma cell lines

Relationship between asparagine synthetase expression level and cell sensitivity to L-asparaginase in human leukemic cell lines]

Asparagine synthetase expression is associated with the sensitivity to asparaginase in extranodal natural killer/T-cell lymphoma in vivo and in vitro.

Targeting Asparagine and Autophagy for Pulmonary Adenocarcinoma Therapy.

Glycyrrhizin suppresses lung adenocarcinoma cell growth through inhibition of thromboxane synthase.

Low expression of long non-coding RNA ARAP1-AS1 can inhibit lung cancer proliferation by inducing G0/G1 cell cycle organization

Elevated Asparagine Biosynthesis Drives Brain Tumor Stem Cell Metabolic Plasticity and Resistance to Oxidative Stress

Abstract 6030: Asparagine metabolism is linked to sex differences in colorectal cancer growth

Asparagine Synthetase is Partially Localized to the Plasma Membrane and Upregulated by L-asparaginase in U937 Cells

Enhanced Expression of Asparagine Synthetase under Glucose-Deprived Conditions Protects Pancreatic Cancer Cells from Apoptosis Induced by Glucose Deprivation and Cisplatin.

γ-Glutamylcyclotransferase Knockdown Inhibits Growth of Lung Cancer Cells Through G0/G1 Phase Arrest.

ASNS Can Predict the Poor Prognosis of Clear Cell Renal Cell Carcinoma